I-Mab ADR (NASDAQ: IMAB): Stock Performance & Trend Analysis

In today’s recent session, 0.47 million shares of the I-Mab ADR (NASDAQ:IMAB) have been traded, and its beta is 1.07. Most recently the company’s share price was $1.21, and it changed around $0.17 or 16.35% from the last close, which brings the market valuation of the company to $95.32M. IMAB at last check was trading at a discount to its 52-week high of $2.00, offering almost -65.29% off that amount. The share price’s 52-week low was $0.60, which indicates that the recent value has risen by an impressive 50.41% since then. We note from I-Mab ADR’s average daily trading volume that its 10-day average is 0.13 million shares, with the 3-month average coming to 199.04K.

I-Mab ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended IMAB as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.

I-Mab ADR (NASDAQ:IMAB) trade information

Instantly IMAB has been showing a green trend so far today with a performance of 16.35% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.2798 on recent trading dayincreased the stock’s daily price by 5.45%. The company’s shares are currently up 42.35% year-to-date, but still up 32.44% over the last five days. On the other hand, I-Mab ADR (NASDAQ:IMAB) is 49.29% up in the 30-day period. We can see from the shorts that 0.26 million shares have been sold at a short interest cover period of 1.1 day(s).

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 28.36%.

IMAB Dividends

I-Mab ADR’s next quarterly earnings report is expected to be released on 2025-May-14.

I-Mab ADR (NASDAQ:IMAB)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 11.18% of I-Mab ADR shares, and 29.54% of them are in the hands of institutional investors. The stock currently has a share float of 33.26%. I-Mab ADR stock is held by 34.0 institutions, with HHLR ADVISORS, LTD. being the largest institutional investor. By 2024-06-30, it held 7.7935% of the shares, which is about 6.91 million shares worth $11.54 million.

CALIGAN PARTNERS LP, with 3.8067% or 3.37 million shares worth $5.64 million as of 2024-06-30, holds the second largest percentage of outstanding shares.

abrdn Healthcare Investors and abrdn Healthcare Opportunities Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 53.88 shares worth $64662.0, making up 0.07% of all outstanding shares. On the other hand, abrdn Healthcare Opportunities Fund held roughly 43.74 shares worth around $52485.0, which represents about 0.05% of the total shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.